Authors: Vreeburg, EM Levi, M Rauws, EAJ Deventer, SJHV Snel, P Bartelsman, JWFM Ten Cate, JW Tytgat, GNJ

Citation: Em. Vreeburg et al., Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhageand the beneficial effect of acid suppression, ALIM PHARM, 15(5), 2001, pp. 639-646

Authors: Schenk, BE Kuipers, EJ Nelis, GF Bloemena, E Thijs, JC Snel, P Luckers, AEG Klinkenberg-Knol, EC Festen, HPM Viergever, PP Lindeman, J Meuwissen, SGM

Citation: Be. Schenk et al., Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy, GUT, 46(5), 2000, pp. 615-621

Authors: Klinkenberg-Knol, EC Nelis, F Dent, J Snel, P Mitchell, B Prichard, P Lloyd, D Havu, N Frame, MH Roman, J Walan, A

Citation: Ec. Klinkenberg-knol et al., Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa, GASTROENTY, 118(4), 2000, pp. 661-669

Authors: Schenk, BE Kuipers, EJ Klinkenberg-Knol, EC Bloemena, EC Sandell, M Nelis, GF Snel, P Festen, HPM Meuwissen, SGM

Citation: Be. Schenk et al., Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B-12 levels, ALIM PHARM, 13(10), 1999, pp. 1343-1346

Authors: Vreeburg, EM Terwee, CB Snel, P Rauws, EAJ Bartelsman, JFWM van der Meulen, JHP Tytgat, GNJ

Citation: Em. Vreeburg et al., Validation of the Rockall risk scoring system in upper gastrointestinal bleeding, GUT, 44(3), 1999, pp. 331-335

Authors: Festen, HPM Schenk, E Tan, G Snel, P Nelis, F

Citation: Hpm. Festen et al., Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: Short- and long-term treatment, AM J GASTRO, 94(4), 1999, pp. 931-936